KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny 
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
NEW YORK, Feb. 17, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of investors who purchased Nobilis Health Corp. (NYSE:HLTH) securities between April 2, 2015 and January 6, 2016.
Click here to learn about the case: http://docs.wongesq.com/HLTH-Info-Request-Form-951. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Nobilis’ financial statements contained numerous errors concerning the classification of warrants and options, business combination accounting, share-based compensation, and other financial and operating results; (2) Nobilis overstated its net income for the year ended December 31, 2014 by more than $4 million; (3) Nobilis overstated its net income for the quarter ended March 31, 2015 by more than $3.27 million; and (4) as a result, defendants’ statements about Nobilis’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
If you suffered a loss in Nobilis Health you have until March 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/HLTH-Info-Request-Form-951.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
